Astrazeneca Lp, Aktiebolaget Draco, Kbi Inc., and Kbi-Einc. v. Mylan Pharmaceuticals Inc.

NOTE: This disposition is nonprecedential.
United States Court of Appeals
for the Federal Circuit
______________________
ASTRAZENECA LP, AKTIEBOLAGET DRACO,
KBI INC., AND KBI-E INC.,
Plaintiffs-Appellants,
v.
MYLAN PHARMACEUTICALS INC.,
Defendant-Appellee.
____________________
2011-1506
______________________
Appeal from the United States District Court for the
District of Delaware in No. 08-CV-0453, Chief Judge
Gregory M. Sleet.
______________________
JUDGMENT
______________________
G EORGE F. PAPPAS , Covington & Burling LLP, of
Washington, DC, argued for plaintiffs-appellants. With
him on the brief were JEFFREY B. ELIKAN and M ICHELLE
L. M ORIN .
NICOLE W. STAFFORD , Wilson Sonsini Goodrich &
Rosati, of Austin, Texas, argued for defendant-appellee.
With her on the brief were ROBERT D ELAFIELD ; D AVID S.

-- 1 of 2 --

STEUER and M ATTHEW A. ARGENTI, of Palo Alto,
California.
______________________
THIS CAUSE having been heard and considered, it is
O RDERED and ADJUDGED :
PER CURIAM ( RADER, Chief Judge, PLAGER and LOURIE,
Circuit Judges).
AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY O RDER OF THE COURT
April 9, 2012 /s/ Jan Horbaly
Date Jan Horbaly
Clerk

-- 2 of 2 --